These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28965312)

  • 1. A Comparison of Adverse Drug Reaction Profiles in Patients on Antiretroviral and Antitubercular Treatment in Zimbabwe.
    Masuka JT; Chipangura P; Nyambayo PP; Stergachis A; Khoza S
    Clin Drug Investig; 2018 Jan; 38(1):9-17. PubMed ID: 28965312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacovigilance study of adults on highly active antiretroviral therapy, South Africa: 2007 - 2011.
    Dube NM; Summers R; Tint KS; Mayayise G
    Pan Afr Med J; 2012; 11():39. PubMed ID: 22593775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Effectiveness of Highly Active Antiretroviral Therapy in Treatment-Naïve HIV Patients: Preliminary Findings of a Cohort Event Monitoring Study in Belarus.
    Setkina S; Dotsenko M; Bondar S; Charnysh I; Kuchko A; Kaznacheeva A; Kozorez E; Dodaleva A; Rossa N
    Drug Saf; 2015 Apr; 38(4):365-72. PubMed ID: 25808626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions associated with antiretroviral therapy in South Africa.
    Birbal S; Dheda M; Ojewole E; Oosthuizen F
    Afr J AIDS Res; 2016 Sep; 15(3):243-8. PubMed ID: 27681148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infection.
    Sagwa E; Ruswa N; Musasa JP; Mantel-Teeuwisse AK
    Drug Saf; 2013 Nov; 36(11):1087-96. PubMed ID: 23917883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India.
    Anwikar SR; Bandekar MS; Smrati B; Pazare AP; Tatke PA; Kshirsagar NA
    Int J Risk Saf Med; 2011; 23(3):163-9. PubMed ID: 22020396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of the trends, characteristics, scope, and performance of the Zimbabwean pharmacovigilance reporting scheme.
    Masuka JT; Khoza S
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00657. PubMed ID: 32930524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs.
    Marks DJ; Dheda K; Dawson R; Ainslie G; Miller RF
    Int J STD AIDS; 2009 May; 20(5):339-45. PubMed ID: 19386972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study.
    Namme Luma H; Doualla MS; Choukem SP; Temfack E; Ashuntantang G; Achu Joko H; Koulla-Shiro S
    Pan Afr Med J; 2012; 12():87. PubMed ID: 23077708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in Uganda.
    Ndagije H; Nambasa V; Namagala E; Nassali H; Kajungu D; Sematiko G; Olsson S; Pal S
    Drug Saf; 2015 Apr; 38(4):395-408. PubMed ID: 25749663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.
    Kumarasamy N; Venkatesh KK; Cecelia AJ; Devaleenal B; Lai AR; Saghayam S; Balakrishnan P; Yepthomi T; Poongulali S; Flanigan TP; Solomon S; Mayer KH
    AIDS Patient Care STDS; 2008 Apr; 22(4):337-44. PubMed ID: 18422462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor.
    Rakotoambinina B; Médioni J; Rabian C; Jubault V; Jais JP; Viard JP
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):443-9. PubMed ID: 11511820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis.
    Mann M; Mengistu A; Gaeseb J; Sagwa E; Mazibuko G; Babigumira JB; Garrison LP; Stergachis A
    Drug Saf; 2016 Sep; 39(9):859-72. PubMed ID: 27314405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
    Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports.
    Njuguna C; Stewart A; Mouton JP; Blockman M; Maartens G; Swart A; Chisholm B; Jones J; Dheda M; Igumbor EU; Cohen K
    Drug Saf; 2016 Feb; 39(2):159-69. PubMed ID: 26547719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV Positive Patients in Imam Khomeini Hospital of Tehran, Iran.
    Koochak HE; Babaii A; Pourdast A; Golrokhy R; Rasoolinejad M; Khodaei S; Moghadam SRJ; Taheri RR; Seyed Alinaghi SA
    Infect Disord Drug Targets; 2017; 17(2):116-119. PubMed ID: 28164754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.
    Dean GL; Edwards SG; Ives NJ; Matthews G; Fox EF; Navaratne L; Fisher M; Taylor GP; Miller R; Taylor CB; de Ruiter A; Pozniak AL
    AIDS; 2002 Jan; 16(1):75-83. PubMed ID: 11741165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients.
    Tetteh RA; Nartey ET; Lartey M; Mantel-Teeuwisse AK; Leufkens HG; Yankey BA; Dodoo AN
    Drug Saf; 2016 Nov; 39(11):1139-1149. PubMed ID: 27638659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of adverse events associated with antiretroviral therapy and the relationship to treatment adherence.
    Lenzi L; Wiens A; Pontarolo R
    Int J Clin Pharmacol Ther; 2013 Feb; 51(2):141-6. PubMed ID: 23253950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost of nucleoside analogue reverse transcriptase inhibitor-related toxicity in HIV-1-infected patients].
    Llibre-Codina JM; Casado-Gómez MA; Sánchez-de la Rosa R; Pérez-Elías MJ; Santos-González J; Miralles-Alvarez C; Martínez-Chamorro E; Domingo-Pedrol P; Alvarez-García ML; Moreno-Guillén S
    Enferm Infecc Microbiol Clin; 2007 Feb; 25(2):98-107. PubMed ID: 17288907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.